000			01517 a2200457 4500
005			20250517155642.0
264		0	_c20170731
008			201707s 0 0 eng d
022			_a1557-9859
024	7		_a10.1016/j.mcna.2017.03.002 _2doi
040			_aNLM _beng _cNLM
100	1		_aPletcher, Mark J
245	0	0	_aCardiovascular Risk Assessment. _h[electronic resource]
260			_bThe Medical clinics of North America _cJul 2017
300			_a673-688 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAge Factors
650	0	4	_aAnkle Brachial Index
650	0	4	_aBiomarkers
650	0	4	_aBlood Glucose
650	0	4	_aBlood Pressure
650	0	4	_aBody Mass Index
650	0	4	_aC-Reactive Protein _xanalysis
650	0	4	_aCalcium _xanalysis
650	0	4	_aCardiovascular Diseases _xepidemiology
650	0	4	_aCoronary Vessels _xchemistry
650	0	4	_aExercise
650	0	4	_aGenetic Predisposition to Disease
650	0	4	_aHumans
650	0	4	_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use
650	0	4	_aLipids _xblood
650	0	4	_aRisk Assessment
650	0	4	_aRisk Factors
650	0	4	_aRisk Reduction Behavior
650	0	4	_aSex Factors
650	0	4	_aSmoking _xepidemiology
650	0	4	_aSocioeconomic Factors
700	1		_aMoran, Andrew E
773	0		_tThe Medical clinics of North America _gvol. 101 _gno. 4 _gp. 673-688
856	4	0	_uhttps://doi.org/10.1016/j.mcna.2017.03.002 _zAvailable from publisher's website
999			_c27242225 _d27242225